Loxapine Capsules USP, 10mg, 100 count bottle, Rx only, Manufactured By: Watson Laboratories Inc., Corona, CA 92880 Rx only. NDC # 0591-0370-01
Published July 11, 2012 · Recall initiated: April 17, 2012
Summary
FDA records drug Class III recall D-1400-2012, published July 11, 2012 and initiated April 17, 2012. Recalling firm: Watson Laboratories Inc; Status: Terminated; Reported quantity: 106,323 bottles; Lot: Lot #s: 107886A, 107887A, 112874A, 144274A, 196483A, 201146A, 217265A, 260747B, 283308A, 313279A, 313279B, 327892A, 327893A, 327894A, 387239A, 387240A, 427259A, 427260A, 456251A. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.
What to do
Voluntary: Firm initiated · Letter
Get an email if LOXAPINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LOXAPINE
- Manufacturer
- Watson Laboratories Inc
- Distributor
- Nationwide.
- UPC
- 0305910369019
- Lot
- Lot #s: 107886A, 107887A, 112874A, 144274A, 196483A, 201146A, 217265A, 260747B, 283308A, 313279A, 313279B, 327892A, 327893A, 327894A, 387239A, 387240A, 427259A, 427260A, 456251A.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALoxapine Capsules USP, 50mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CAJuly 11, 2012
- FDALoxapine Capsules USP, 25mg, 100 count bottle, Rx only, Manufactured By: Watson Laboratories Inc., Corona, CAJuly 11, 2012
- FDALoxapine Capsules USP, 5mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CAJuly 11, 2012
- FDALoxitane Capsules, Loxapine Succinate Capsules, 10mg base, 100 count bottle, Rx only, Watson LaboratoriesJuly 11, 2012
- FDAARCHITECT CA 19-9XR Reagent Kit; ARCHITECT CA 19-9 Reagent Kit, list 291-20 (4 x 100 tests), 2K91-25 andJuly 4, 2012
- FDAPTS Panels Creatinine test strips. PTS Panels Creatinine Test Strips are intended to measure creatinine inJuly 4, 2012
Questions about this recall
Was Loxapine Capsules USP, 10mg, 100 count bottle, Rx only, Manufactured By: Watson Laboratories Inc., Corona, CA 92880 Rx only. NDC # 0591-0370-01 recalled?
Yes. FDA published recall D-1400-2012 on July 11, 2012. Reported hazard: Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LOXAPINE. UPC: 0305910369019.